Trial intelligence / Profile preview

Tranexamic acid in sleeve bariatric surgery for bleeding outcomes

RBR-4w39gzPhase 4Completed

Sponsor
Hospital São Domingos
Start
Sep 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of tranexamic acid in obesity (3 arms), sponsored by Hospital São Domingos. Primary endpoint: Bleeding outcome. Started Sep 2018; status: completed.

02

Drugs

tranexamic acid
03

Conditions

obesity

Beyond the preview

Go deeper on RBR-4w39gz.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-4w39gz.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call